BioSpace News Archive

Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the third quarter ended September 30, 2022. Cash and investments in marketable securities on September 30, 2022 , were

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today reported financial results for the three months ended September 30, 2022, and highlighted recent progress.

Myomo, Inc. today announced that it will report financial results for the three and nine months ended September 30, 2022 on November 10, 2022, after the market close.

Alphatec Holdings, Inc., a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced financial results for the quarter ended September 30, 2022, and recent corporate highlights.

Privia Health announced a joint venture and strategic partnership with Novant Health Enterprises, a division of Novant Health, a nationally recognized not-for-profit health system, to launch Privia Medical Group – North Carolina to bring support and resources to independent providers throughout the state.

IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that it will release its third quarter 2022 financial results after market close on Thursday, November 10, 2022.

Vallon Pharmaceuticals, Inc. today reported its financial results for the quarter ended September 30, 2022.

Alpine Immune Sciences, Inc. today presented a poster at the American Society of Nephrology Kidney Week 2022 Meeting highlighting updated clinical data from RUBY-1, a phase 1 healthy volunteer (HV) study of ALPN-303, a dual B cell cytokine antagonist being developed for multiple B cell and/or autoantibody-related diseases.

BostonGene today announced that an abstract has been accepted for online publication for the Association for Molecular Pathology (AMP) 2022 Annual Meeting & Expo, which will be held November 3 - 5, 2022, at the Phoenix Convention Center in Phoenix, AZ. BostonGene will also exhibit at booth 943.

XORTX Therapeutics Inc. is pleased to announce the presentation of a peer-reviewed abstract to be presented November 4, 2022 at the American Society of Nephrology Annual Conference – Kidney Week.